Hong sells AES 14.22: UPDATE: BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
BMO Capital downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Market Perform with ... and a poor adverse event (AE) profile: 48% G3/4 AEs, most leading to discontinuation, and 6.5% drug-related deaths. Although BMS still plans to move ... ...
51 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home